CHRNA7 and early-onset autosomal dominant Alzheimer disease: The α7 nAChR has attracted considerable attention to enhance cognition in neurological and psychiatric disorders associated with cognitive decline such as Alzheimer's disease and schizophrenia (7, –, 11).